Opportunity Information: Apply for CDC RFA GH12 1252
Apply for CDC RFA GH12 1252
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Construction of a Regional Reference Laboratory in Leribe" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Mar 30, 2012 and posted on Mar 23, 2012.
- Applicants must submit their applications by May 16, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,000,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- The only eligible applicant that can apply for this funding opportunity is the Ministry of Health and Social Welfare (MOHSW). The MOHSW is the governmental agency responsible for safeguarding public health in Lesotho. The MOHSW has been mandated by the Government of the Kingdom of Lesotho (GOL) with the responsibility for maintaining a national laboratory system and providing decentralized and integrated laboratory services throughout the country. This responsibility is carried out by the Directorate of Laboratory services of the MOHSW.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Construction of a Regional Reference Laboratory in Leribe" (Funding Opportunity Number CDC RFA GH12-1252) is a U.S. Centers for Disease Control and Prevention (CDC) cooperative agreement focused on strengthening public health laboratory infrastructure in Lesotho under the President's Emergency Plan for AIDS Relief (PEPFAR). The project centers on building a new Regional Reference Laboratory adjacent to Motebang Hospital in Leribe. The overall purpose is to expand access to reliable, quality-assured diagnostic testing and patient monitoring services, especially in response to growing needs linked to HIV and tuberculosis.
A key driver behind the award is that demand for laboratory testing has reportedly doubled in recent years. This increase is tied to multiple overlapping pressures: the high burden of HIV/TB co-epidemics, the expansion of antiretroviral therapy (ART) services (which raises the need for routine patient monitoring tests), and the growing necessity for more advanced tuberculosis diagnostics such as culture and drug susceptibility testing (DST). In practical terms, the opportunity is designed to relieve bottlenecks in testing capacity and help the health system keep up with the clinical and public health requirements of a larger treated population and more complex TB case management.
The proposed regional laboratory is intended to provide a safer and more appropriate working environment for laboratory staff while also increasing both the volume and sophistication of testing that can be performed. Beyond general diagnostic services, the laboratory is expected to expand into specialty testing areas that are particularly important for HIV and TB programs. The announcement specifically highlights microbial and TB culture, DST, patient monitoring services, and specialized molecular testing, including early infant diagnosis (EID) and HIV viral load assays. These services are central to identifying HIV infection in newborns as early as possible, monitoring whether ART is effectively suppressing the virus, and detecting drug-resistant TB so patients can be placed on the right treatment regimen.
Another important aspect of the opportunity is the role the facility will play as a regional reference testing center for Leribe and surrounding districts. Rather than serving only a single hospital, the laboratory is positioned as a hub that can support multiple districts by receiving referrals, standardizing methods, and improving overall quality of testing services. In addition to routine service delivery, the laboratory is also expected to support operational research and trainings, which points to a broader system-building aim: strengthening workforce skills, improving procedures and quality management practices, and generating evidence to improve program performance and patient outcomes.
From an administrative standpoint, the opportunity falls under the Health funding activity category and uses a cooperative agreement mechanism, which typically means the CDC anticipates having substantial programmatic involvement during implementation compared with a standard grant. The estimated total funding listed is $3,000,000, with an award ceiling of $1,000,000, and the expected number of awards is one. The CFDA number is 93.067 (Global AIDS). There is no cost sharing or matching requirement, lowering the financial burden on the recipient for required counterpart funding.
Eligibility for this funding opportunity is highly restricted. The only eligible applicant is the Lesotho Ministry of Health and Social Welfare (MOHSW), identified as the government agency responsible for safeguarding public health and maintaining the national laboratory system. The announcement frames this as part of MOHSW's mandate from the Government of the Kingdom of Lesotho, carried out through the Directorate of Laboratory Services. In other words, this is not an open competition for NGOs or universities; it is structured as a direct investment into government-led laboratory system development.
The opportunity was posted on March 23, 2012, with a creation date of March 30, 2012. The original closing date was May 21, 2012, later adjusted to May 16, 2012, and the archive date is June 20, 2012. For access issues related to the full announcement, the listed contact is the CDC Procurement and Grants Office (PGO) via pgotim@cdc.gov and phone 770-488-2700.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Construction of a Regional Reference Laboratory in Leribe."
What is the Funding Opportunity Number?
The Funding Opportunity Number is CDC RFA GH12-1252.
Which U.S. agency is offering this opportunity?
This is a U.S. Centers for Disease Control and Prevention (CDC) opportunity.
What type of award is this?
The award mechanism is a cooperative agreement. This typically indicates CDC expects substantial programmatic involvement during implementation compared with a standard grant.
What is the main purpose of the project?
The overall purpose is to strengthen public health laboratory infrastructure in Lesotho by expanding access to reliable, quality-assured diagnostic testing and patient monitoring services, with particular emphasis on needs tied to HIV and tuberculosis.
How does this opportunity relate to PEPFAR?
The project is described as part of the President's Emergency Plan for AIDS Relief (PEPFAR), focused on supporting HIV-related and associated laboratory services, including key testing used for HIV and TB programs.
What will be built under this opportunity?
The project centers on building a new Regional Reference Laboratory.
Where will the new laboratory be located?
The laboratory is intended to be constructed adjacent to Motebang Hospital in Leribe, Lesotho.
Why is a new regional reference laboratory needed?
The announcement cites a reported doubling of demand for laboratory testing in recent years. This increase is linked to the high burden of HIV/TB co-epidemics, expansion of antiretroviral therapy (ART) services (which increases routine patient monitoring testing needs), and the growing need for more advanced TB diagnostics such as culture and drug susceptibility testing (DST).
What problem is the project intended to solve?
It is intended to relieve bottlenecks in testing capacity and help the health system keep pace with clinical and public health requirements created by a larger treated population and more complex TB case management needs.
What is meant by "regional reference" in this opportunity?
The laboratory is positioned as a regional reference testing center for Leribe and surrounding districts, acting as a hub to receive referred specimens/testing needs, standardize methods, and improve overall quality of testing services beyond a single hospital.
What types of testing and services are highlighted for the laboratory?
The announcement highlights expanded diagnostic and specialty services including microbial and TB culture, drug susceptibility testing (DST), patient monitoring services, and specialized molecular testing.
What molecular testing is specifically mentioned?
Specialized molecular testing mentioned includes early infant diagnosis (EID) and HIV viral load assays.
How do early infant diagnosis (EID) and HIV viral load testing support HIV programs?
EID supports identifying HIV infection in newborns as early as possible. HIV viral load assays support monitoring whether antiretroviral therapy (ART) is effectively suppressing the virus.
How does TB culture and DST support tuberculosis programs?
TB culture and drug susceptibility testing (DST) support detection of drug-resistant TB so patients can be placed on the appropriate treatment regimen.
Will the new facility address laboratory staff working conditions?
Yes. The laboratory is described as providing a safer and more appropriate working environment for laboratory staff while also increasing the volume and sophistication of testing that can be performed.
Does the opportunity mention training or research activities?
Yes. In addition to routine service delivery, the laboratory is expected to support operational research and trainings, aligning with broader system-building goals such as strengthening workforce skills, improving procedures and quality management practices, and generating evidence to improve program performance and patient outcomes.
What funding activity category does this opportunity fall under?
The opportunity falls under the Health funding activity category.
What is the CFDA number for this opportunity?
The CFDA number is 93.067 (Global AIDS).
How much funding is available?
The estimated total funding listed is $3,000,000.
What is the award ceiling?
The award ceiling is $1,000,000.
How many awards does CDC expect to make?
The expected number of awards is one.
Is cost sharing or matching required?
No. The opportunity states there is no cost sharing or matching requirement.
Who is eligible to apply?
Eligibility is highly restricted. The only eligible applicant is the Lesotho Ministry of Health and Social Welfare (MOHSW).
Are NGOs, universities, or other organizations eligible to apply?
No. The opportunity is not an open competition; it is structured as a direct investment into government-led laboratory system development, with MOHSW as the only eligible applicant.
Why is MOHSW the only eligible applicant?
The announcement identifies MOHSW as the government agency responsible for safeguarding public health and maintaining the national laboratory system, acting through the Directorate of Laboratory Services as part of its mandate from the Government of the Kingdom of Lesotho.
When was the opportunity posted?
The opportunity was posted on March 23, 2012.
What is the creation date listed for the opportunity?
The creation date is March 30, 2012.
What was the application closing date?
The original closing date was May 21, 2012, and it was later adjusted to May 16, 2012.
When was the opportunity archived?
The archive date is June 20, 2012.
Who should be contacted for access issues related to the full announcement?
For access issues, the listed contact is the CDC Procurement and Grants Office (PGO).
What are the contact details for the CDC Procurement and Grants Office (PGO)?
Email: pgotim@cdc.gov
Phone: 770-488-2700
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Partners for Fish and Wildlife
Previous opportunity: Developing Innovative Methodologies and Device Specific Infrastructure through the Medical Device Epidemiology Network Applications for Medical Countermeasure Associated Devices (U01)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH12 1252
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH12 1252) also looked into and applied for these:
| Funding Opportunity |
|---|
| Caribbean Regional Epidemiology and Laboratory Training Program (RELTP) under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1206 Funding Number: CDC RFA GH12 1206 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,300,000 |
| Offender Reentry Program Apply for TI 12 003 Funding Number: TI 12 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $400,000 |
| The HIV/AIDS Partnership Impact through Prevention, Private Sector and Evidence based Programming (PIPPSE) Apply for RFA 386 12 000001 Funding Number: RFA 386 12 000001 Agency: India USAID New Delhi Category: Health Funding Amount: $38,000,000 |
| Fostering Local Capacity By Working With New Development Partners Apply for APS NUMBER 663 12 000001 Funding Number: APS NUMBER 663 12 000001 Agency: Ethiopia USAID Addis Ababa Category: Health Funding Amount: $5,000,000 |
| Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R01) Apply for PA 12 131 Funding Number: PA 12 131 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Improving Translational and Basic Research to Control Itch in Humans (ITCH) (R21) Apply for PA 12 132 Funding Number: PA 12 132 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Provision of Comprehensive HIV/AIDS Services and Developing National Capacity to Manage HIV/AIDS Programs in the Republic of Uganda under the Presidents Plan for AIDS Relief Apply for CDC RFA GH12 1213 Funding Number: CDC RFA GH12 1213 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,588,471 |
| State Public Health Approaches to Improving Arthritis Outcomes Apply for CDC RFA DP12 1210 Funding Number: CDC RFA DP12 1210 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Coordinating Center for Research and Training to Promote the Health of People with Developmental and Other Disabilities Apply for RFA DD 12 006 Funding Number: RFA DD 12 006 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,700,000 |
| Primary Care Training and Enhancement Physician Assistant Training in Primary Care Program Apply for HRSA 12 024 Funding Number: HRSA 12 024 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Validating Data found in Linked 2003 Version of Vital Records and Hospital Discharge Data for Quality Improvement in the States Apply for CDC RFA DP12 1201 Funding Number: CDC RFA DP12 1201 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $125,000 |
| HIV Early Intervention Services (EIS) Program Limited Competitive Service Areas (San Francisco, CA and Columbia, SC) Apply for HRSA 12 175 Funding Number: HRSA 12 175 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Cardiovascular Risk Reduction in Underserved Rural Communities (R01) Apply for RFA HL 13 013 Funding Number: RFA HL 13 013 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Children and Adults with Attention Deficit Hyperactivity Disorder (CHADD) Apply for CDC RFA DD07 7140501SUPP12 Funding Number: CDC RFA DD07 7140501SUPP12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Advanced Education Nursing Traineeship (AENT) Program Apply for HRSA 12 062 Funding Number: HRSA 12 062 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening National Pediatric HIV/AIDS and Scaling up Comprehensive HIV/AIDS Services in the Republic of Uganda under The Presidents Emergency Plan For AIDS Relief Apply for CDC RFA GH12 1215 Funding Number: CDC RFA GH12 1215 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $5,000,000 |
| NHLBI Systems Biology Collaborations (R01) Apply for PAR 12 138 Funding Number: PAR 12 138 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Engaging Indigenous Organizations to Sustain and Enhance Comprehensive Clinical Services for the Prevention, Care and Treatment of HIV/AIDS in the Federal Republic of Nigeria under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1210 Funding Number: CDC RFA GH12 1210 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $160,000,000 |
| Sample Vital Registration with Verbal Autopsy in the the Republic of Zambia under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 1245 Funding Number: CDC RFA GH12 1245 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,150,000 |
| NHLBI Career Transition Award (K22) Apply for PAR 12 137 Funding Number: PAR 12 137 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH12 1252", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.